# Driving Behaviours Among Medical Cannabis Patients: UNSW Study > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/prescribed-cannabis-driving-behaviours-clinical-insights/ > **Published:** 2026-02-25T10:18:24-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T11:14:10-04:00 > **Clinical Summary:** Explore prescribed cannabis driving behaviours and clinical insights on THC impairment and patient safety behind the wheel. --- ✦ New CED Clinical Relevance #75 Strong Clinical Relevance High-quality evidence with meaningful patient or clinical significance. ResearchSafetyTHCPolicyDosing Why This Matters If you are a [medical cannabis](https://cedclinic.com/therapeutic-benefits-of-thc/) patient who drives, understanding the specific timing and formulation of your medication is critical to both your legal safety and your actual ability to operate a vehicle without impairment. Clinical Summary Research examining driving behaviors among [medical cannabis](https://cedclinic.com/therapeutic-benefits-of-thc/) patients raises important questions about how THC affects psychomotor function, reaction time, and judgment at various doses and time points after consumption. The relationship between measured THC levels and actual impairment is complex, as tolerance, route of administration, and individual pharmacokinetics all influence functional capacity behind the wheel. Clinicians prescribing cannabis have a responsibility to counsel patients clearly about timing of use relative to driving, particularly when THC-dominant formulations are involved. Dr. Caplan’s Take “Conflating THC blood levels with driving impairment is like equating a breathalyzer reading with surgical incompetence, and until we have validated, standardized impairment testing, both patients and clinicians are navigating policy built on shaky science.” Clinical Perspective A new Australian study examining driving behaviors among 806 medical cannabis patients provides important real-world data for clinical practice. The findings highlight that prescribed [cannabis use](https://cedclinic.com/cannabis-cardiovascular-health-insights-2024/) does not uniformly affect all patients’ driving capabilities in the same way, underscoring the importance of individualized assessment. Clinicians should routinely discuss driving safety with cannabis patients, considering factors like dosing, strain type, time of administration, and individual sensitivity. ️ This research supports evidence-based counseling that moves beyond one-size-fits-all warnings while still prioritizing patient and public safety. Understanding these nuanced patterns helps practitioners make informed recommendations tailored to each patient’s circumstances and tolerance profile. 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/) Have thoughts on this? Share it: [𝕏 Share on X](https://twitter.com/intent/tweet?text=Just+read+this+on+CEDclinic.com%3A+Prescribed+%3Cb%3Ecannabis%3C%2Fb%3E+and+driving+behaviours+among+two+samples+of+people+who+regularly+...+-+UN...+%40drcaplan&url=https%3A%2F%2Fwww.unsw.edu.au%2Fresearch%2Fndarc%2Fresources%2Fprescribed-cannabis-and-driving-behaviours-national-2025) [in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A%2F%2Fwww.unsw.edu.au%2Fresearch%2Fndarc%2Fresources%2Fprescribed-cannabis-and-driving-behaviours-national-2025) [🦅 Share on BlueSky](https://bsky.app/intent/compose?text=Just+read+this%3A+Prescribed+%3Cb%3Ecannabis%3C%2Fb%3E+and+driving+behaviours+among+two+samples+of+people+who+regularly+...+-+UN...+%E2%80%94+via+%40drcaplan.bsky.social+https%3A%2F%2Fwww.unsw.edu.au%2Fresearch%2Fndarc%2Fresources%2Fprescribed-cannabis-and-driving-behaviours-national-2025) [📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan/) [📝 Read more on Substack](https://substack.com/@doctorapproved) [🔔 Subscribe via RSS](https://cedclinic.com/category/cannabis-news/feed/) 📰 Source: [https://www.unsw.edu.au/research/ndarc/resources/prescribed-cannabis-and-driving-behaviours-national-2025](https://www.unsw.edu.au/research/ndarc/resources/prescribed-cannabis-and-driving-behaviours-national-2025) Further Reading Cannabis Memes[College is hard lmao](https://cedclinic.com/college-is-hard-lmao/) CED Clinic Blog[Cannabis-Infused Beverages as Alcohol Alternatives: New York at Five Years](https://cedclinic.com/cannabis-beverage-substitution-alcohol-new-york-five-years/) Policy Watch[Schedules of Controlled Substances: Temporary Placement of N-Desethyl Isotonitazene and N-Piperidinyl Etonitazene in Schedule I](https://cedclinic.com/dea-temporary-placement-schedule-i-n-desethyl-isotonitazene/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence [Co-use of Cannabis Edibles and Alcohol Increases Driving Impairment, suggests JAMA study](https://cedclinic.com/co-use-of-cannabis-edibles-and-alcohol-increases-driving-impairment-suggests-jama-study/) This study explores how combining [cannabis edibles](https://cedclinic.com/decarboxylating-cannabis-process-why-how/) with alcohol significantly increases driving impairment beyond legal limits. [Read More](https://cedclinic.com/co-use-of-cannabis-edibles-and-alcohol-increases-driving-impairment-suggests-jama-study/) [420 with CNW – Texas Grapples with Increasing Cases of Marijuana DUI](https://cedclinic.com/texas-marijuana-dui-laws-challenges-clinical-insights/) An overview of rising [marijuana DUI](https://cedclinic.com/cannabis-impaired-driving-research-safe-driving/) cases in Texas and the challenges faced by law enforcement and policymakers. [Learn More](https://cedclinic.com/texas-marijuana-dui-laws-challenges-clinical-insights/) [Observational study on medical marijuana use seeks Arizona participants – KJZZ](https://cedclinic.com/observational-medical-cannabis-study-arizona/) Join a study investigating [medical marijuana](https://cedclinic.com/cannabis-cardiovascular-risk-impact/) use patterns and its effects, including driving behaviours among patients. [Join Study](https://cedclinic.com/observational-medical-cannabis-study-arizona/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).